[Determination of the antigenic specificity of the neuraminidase of influenza viruses]. 1983

E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia

The principal possibility of using beta-propiolactone-inactivated and lyophilized antigens of influenza A and B viruses and of mouse immune ascitic fluids to them for the determination of the antigenic specificity of neuraminidase has first been established. A simpler and easier method requiring no expensive reagents: inhibition of influenza virus release from erythrocytes was tested. This method is as specific as the labour-consuming and difficult test of neuraminidase activity inhibition, and allows a rapid and accurate identification of the type of neuraminidase of influenza viruses of various origins to be made.

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
March 1997, Virology,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
January 1989, Voprosy virusologii,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
January 1985, Voprosy virusologii,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
January 1983, Voprosy virusologii,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
January 1975, Annales de recherches veterinaires. Annals of veterinary research,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
September 2022, Pharmaceuticals (Basel, Switzerland),
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
December 2011, Proceedings of the National Academy of Sciences of the United States of America,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
November 2012, Proceedings of the National Academy of Sciences of the United States of America,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
June 2011, Virology,
E V Molibog, and Ia M Selivanov, and E I Mel'nichenko, and V A Isachenko, and L Ia Zakstel'skaia
January 1983, Voprosy virusologii,
Copied contents to your clipboard!